Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy, Irene Ganan-Gomez, Hui Yang, Feiyang Ma, Guillermo Montalban-Bravo, Natthakan Thongon, Valentina Marchica, Guillaume Richard-Carpentier, Kelly Chien, Ganiraju Manyam, Feng Wang, Ana Alfonso, Shuaitong Chen, Caleb Class, Rashmi Kanagal-Shamanna, Justin P. Ingram, Yamini Ogoti, Ashley Rose, Sanam Loghavi, Pamela Lockyer, Benedetta Cambo, Muharrem Muftuoglu, Sarah Schneider, Vera Adema, Michael McLellan, John Garza, Matteo Marchesini, Nicola Giuliani, Matteo Pellegrini, Jing Wang, Jason Walker, Ziyi Li, Koichi Takahashi, Joel D. Leverson, Carlos Bueso-Ramos, Michael Andreeff, Karen Clise-Dwyer, Guillermo =Garcia-Manero, Simona Colla
Scholarship and Professional Work – COPHS

Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers, David Peng, B. Rodriguez, Lixia Diao, Pierre Gaudreau, Aparna Padhye, Joshua Ochieng, Caleb Class, Jared Fradette, Laura Gibson, Limo Chen, Jing Wang, Lauren Byers, Don Gibbons
Scholarship and Professional Work – COPHS

CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-l1 blockade, Limo Chen, Lixia Diao, Yongbin Yang, Xiaohui Yi, B. Rodriguez, Yanli Li, Yanli Li, Pamela Villalobos, Tina Cascone, Xi Liu, Lin Tan, Philip Lorenzi, Anfei Huang, Qiang Zhao, Di Peng, Jared Fradette, David Peng, Christin Ungewiss, Jonathon Roybal, Pan Tong, Junna Oba, Ferdinandos Skoulidis, Weiyi Peng, Brett Carter, Youhong Fan, Caleb Class, Jingfen Zhu, Jaime Rodriguez-Canales, Masanori Kawakami, Lauren Byers, Scott Woodman, Vassiliki Papadimitrakopoulou, Ethan Dmitrovsky, Jing Wang, Stephen Ullrich, Ignacio Wistuba, John Heymach, F. Qin, F. Qin, Don Gibbons
Scholarship and Professional Work – COPHS